The transcription factor ThPOK promotes CD4 + T cell differentiation in the thymus. Here, using a mouse strain that allows post-thymic gene deletion, we show that ThPOK maintains CD4 + T lineage integrity and couples effector differentiation to environmental cues after antigenic stimulation. ThPOK preserved the integrity and amplitude of effector responses, and was required for proper T H 1 and T H 2 differentiation in vivo by restraining the expression and function of the transcriptional regulator of cytotoxic T cell differentiation, Runx3. The transcription factor LRF contributed in a redundant manner with ThPOK to prevent the trans-differentiation of mature CD4 + T cells into CD8 + T cells. As such, the ThPOK-LRF transcriptional module was essential for CD4 + T cell integrity and responses. CD4 + T cells typically recognize peptide antigens presented by the class II major histocompatibility complex (MHC class II) molecules, and upon activation differentiate into Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms 
subtypes of effector helper T cells (T H ) expressing specific transcription factors and cytokines 1, 2 . Such effector T cell fates include T H 1, which express interferon γ (IFN-γ) and the transcription factors T-bet and Runx3, T H 2, which express interleukin 4 (IL-4) IL-13 and the transcription factor GATA3, or T H 17, which express IL-17 and the transcription factor RORγt. In contrast, MHC class I-restricted T cells express CD8 and typically differentiate into cytotoxic effectors after antigen stimulation 3 .
CD4 + and CD8 + T cells differentiate in the thymus from CD4 + CD8 + (double positive, DP) precursors that lack functional potential 4 . Commitment to either lineage involves the mutually exclusive expression of two transcription factors, ThPOK and Runx3 [5] [6] [7] [8] , so that CD4 + T cells express ThPOK but no Runx3, whereas the opposite is true of CD8 + T cells 9 . Current views propose that these factors participate in a dual negative regulatory loop, in which ThPOK represses the genes encoding Runx3 and CD8 subunits (CD8α and CD8β), and Runx3, redundantly with the related molecule Runx1, represses those encoding ThPOK and CD4 [10] [11] [12] [13] . Such a model accounts for the observation that intrathymic or germline disruption of ThPOK unleashes Runx3 expression and 'redirects' MHC class II-restricted thymocytes into CD8 + T cells 7 .
In addition to controlling CD4 and CD8 expression, ThPOK contributes to thymocyte functional differentiation. Even though effector differentiation is manifest only upon antigen activation, mature thymocytes are functionally 'pre-programmed' as helper or cytotoxic and express genes specific of either fate 9 . Redundantly with the related transcription factor LRF 14 , ThPOK is required in the thymus for helper 'pre-programming', as ThPOK and LRF-deficient MHC II-restricted thymocytes fail to express CD40L, a CD4 + -lineage specific molecule involved in multiple aspects of CD4 + T cell function 15 , and to give rise to functional T H cells 16 .
Although ThPOK remains highly expressed in peripheral CD4 + T cells 7, [10] [11] [12] , little is known about its role in these cells, whether before (naïve T cells) or after (T effector cells) antigen contact. Because T H 1 effector cells co-express ThPOK and Runx3, it remains unclear whether post thymic ThPOK represses Runx3. While ThPOK disruption increases the expression of the cytotoxic enzyme Granzyme B and that of IFN-γ in CD4 + T effector cells 10 , the biological impact of ThPOK disruption remains to be determined. It has been proposed that ThPOK expression in intestinal CD4 + T cells promotes gut inflammation by sustaining T H 17 responses 17 , but whether ThPOK affects CD4 + T effector cell differentiation in vivo remains unknown.
In this study, we used a mouse strain expressing the Cre recombinase in post-thymic T cells to inactivate ThPOK in naïve CD4 + T cells, prior to activation and effector differentiation. We show that post-thymic ThPOK restrains the expression of Runx3 in resting and activated CD4 + T cells and is needed for T H 2, but not for T H 17, effector responses. In addition, even though Runx3 promotes expression of the T H 1 cytokine IFN-γ 18, 19 , ThPOK was required for T H 1 differentiation and prevented the diversion of T H 1 CD4 + cells to a cytotoxic gene expression program. Last, we demonstrate that ThPOK and LRF redundantly prevented the trans-differentiation of CD4 + into CD8 + T cells. These findings demonstrate that ThPOK is essential to preserve the functional diversity of CD4 + T cells and the proper matching of CD4 + effector responses to the cytokine environment conditioning effector differentiation.
Results

Post-thymic Thpok inactivation in resting CD4 + T cell
To evaluate the post-thymic functions of ThPOK, we conditionally disrupted Zbtb7b (the gene encoding ThPOK, thereafter called Thpok) using a Cre recombinase transgene driven by the human CD2 promoter. Contrary to other CD2-driven transgenes, this construct is not active in most DP and CD4SP thymocytes, but is upregulated after thymic development; thus, it ensures efficient deletion in peripheral CD4 + T cells, as shown with a Rosa26 YFP reporter for Cre activity (Fig. 1a) . Deletion was also efficient in CD8 + T cells, and was already substantial in CD8SP thymocytes ( Supplementary Fig. 1a ), consistent with CD8SP thymocytes taking longer than CD4SP cells to develop from DP thymocytes 20, 21 . Consistent with this expression pattern, and unlike thymic (germline or Cd4-Cre-mediated) Thpok disruption 7, 11, 12, 22 , Thpok fl/fl CD2-Cre mice (hereafter called Thpok pd for 'peripheral deleter') had large numbers of CD4SP thymocytes, which expressed a normal amount of ThPOK protein (Fig. 1b,c and Supplementary Fig. 1b) . Furthermore, and contrasting with thymic deletion, Thpok pd mice had CD4 + CD8 − naïve T cells, most of which expressed Rosa26 YFP ( Fig. 1d and Supplementary Fig. 1c ) and little or no ThPOK (Fig. 1c) . Thus, this experimental system is suitable to study post-thymic functions of ThPOK. Of note, deletion was incomplete in Foxp3-expressing regulatory T cells 1 (T reg )( Supplementary Fig. 1d ), whether in the thymus or in the spleen, making this system poorly suited to study ThPOK function in T reg cells.
Thpok pd mice had fewer CD4 + CD8 − T cells than wild-type mice ( Supplementary Fig. 1c ). However, Thpok pd mice had unusual CD4 lo CD8 − (hereafter CD4 lo ) and CD4 + CD8 + (peripheral DP, hereafter pDP) cells, which expressed Rosa26 YFP and were predominantly naive (CD44 lo ; Fig. 1d) ; as a result, the total number of CD4 + T cells (including CD4 lo and pDP) was similar in Thpok pd and wild-type mice ( Fig. 1e and Supplementary Fig. 1c ). Whereas preselection DP thymocytes are TCR lo , pDP cells were TCR hi (data not shown); pDP cells expressed both CD8α and CD8β subunits (Fig. 1f) , unlike the small subset of CD4 + CD8α + β − cells normally found among gut intraepithelial lymphocytes (IELs) 23 . Upon adoptive transfer into lympho-replete recipients, purified Thpok pd CD4 + T cells gave rise to pDP and CD4 lo peripheral T cells (Fig. 1g) . The transferred cells remained naïve (CD44 lo ), confirming that changes in CD4 or CD8 expression occurred without proliferation. Of note, unlike thymic Thpok disruption, very few transferred CD4 + T cells became CD4 − CD8 + . Thus, post-thymic ThPOK is needed for the proper control of CD4 and CD8 coreceptor gene expression in naïve MHC class II-restricted T cells.
ThPOK represses Runx3 in thymocytes, so that MHC II-signaled thymocytes that are ThPOK deficient up-regulate Runx3 to a level characteristic of MHC I-restricted CD8SP thymocytes 12 . To examine if ThPOK represses Runx3 in peripheral T cells, we generated Thpok pd mice carrying a Runx3 dYFP allele that reports Runx3 expression 12 . Contrary to Thpok +/+ CD4 + T cells, about half of naïve Thpok pd CD4 lo and pDP cells expressed Runx3 (Fig. 1h) ; thus, post-thymic ThPOK restrains expression of Runx3 in naïve CD4 + T cells.
However, most Thpok pd CD4 + CD8 − T cells failed to express Runx3 dYFP , and immunoblot analyses only found low expression of Runx3 protein in these cells ( Supplementary Fig. 1e ). Thus, unlike in thymocytes, ThPOK is not required for Runx3 repression in mature CD4 + T cells.
To evaluate the impact of Runx3 de-repression, we generated Thpok pd Cbfb pd mice, which inactivate ThPOK and the obligatory Runx cofactor Cbfβ post-thymically. We targeted Cbfβ, rather than Runx3, because of the overlapping activities of Runx1 and Runx3 in thymocytes and T cells 24 . Post-thymic disruption of Cbfβ, whether alone or in addition to that of ThPOK, had little impact on thymic development ( Supplementary Fig. 1f,g ). However, Thpok pd Cbfb pd mice had no peripheral CD4 lo T cells (Fig. 1i,j) , suggesting that Runx3 up-regulation mediates Cd4 repression in Thpok pd cells. Of note, there were pDP cells in Thpok pd Cbfb pd mice; however, the presence of these cells did not imply that Runx activity was dispensable for CD8 re-expression, because Cbfβ inactivation may impair Cd4 silencing in CD8 + T cells 24 . We conclude from these experiments that post-thymic ThPOK protects CD4 + T lineage integrity, at least in part by restraining Runx3 expression.
Conserved T H 17 potential of Thpok-deficient cells
Having shown that ThPOK preserves the differentiation of resting CD4 + T cells, we examined its functions during T cell effector differentiation. Because it was recently reported that ThPOK was important for T H 17 differentiation through restraining Runx3 expression 17 , we assessed T H 17 responses in the large intestine lamina propria (liLP) and draining (mesenteric) lymph nodes of mice. Both at steady state or after infection with Citrobacter rodentium, an enterobacterium that generates a strong colonic T H 17 response 25 , Thpok pd mice had a higher frequency of T H 17 cells than wild-type mice (Fig. 2a,b, (Fig. 2b) . Accordingly, the course of Citrobacter rodentium infection was similar in wild type and Thpok pd mice ( Supplementary Fig. 2a,b) . Consistent with these results, IL-17 expression was conserved in Thpok pd T effector cells generated in vitro in T H 17 polarizing conditions. Although the frequency of IL-17 + T cells was modestly increased by ThPOK disruption (Fig. 2d) , there was no effect on IL-17 cytokine production assessed by ELISA ( Supplementary Fig. 2c) , and little or no change in Runx3, IFN-γ or granzyme B expression (Fig. 2d ,e and S2d). Altogether, these experiments support the conclusion that T H 17 differentiation of naïve CD4 + T cells does not require ThPOK.
Thpok protects T H 2 responses by repressing Runx3
We previously showed that the MHC II-restricted CD8 + T cells generated following thymic Thpok disruption fail to undergo T H 2 differentiation, whether in vitro or in vivo 16 . In contrast, naïve Thpok pd cells made IL-4 when activated in vitro in T H 2 polarizing conditions (Fig. 3a) . To elucidate the role of ThPOK expression during T H 2 responses in vivo, we immunized mice with inactivated Schistosoma mansoni eggs 26 . While this typical T H 2 stimulus induces CD4 + CD8 − T cells expressing IL-4 or the T H 2 regulator GATA3 27 in wild-type mice, there was almost no T cells expressing GATA3 or IL-4 in Thpok pd mice (Fig.  3b) . These results suggest ThPOK is important for T H 2 differentiation in vivo, Accordingly, expression of IL-4, assessed by intra-cellular staining or ELISA of IL-4 secretion, and expression of GATA3 were markedly impaired when naive Thpok pd CD4 + T cells were activated in non polarizing conditions, which normally favor T H 2 differentiation (Fig. 3c,d and Supplementary Fig. 3a,b) . Instead, in these conditions, Thpok pd CD4 + T cells made IFN-γ and the cytotoxic enzyme Granzyme B (Fig. 3d, g ), and expressed CD8 (both CD8α and CD8β) (Fig. 3e,f) , and Eomesodermin (Eomes), a T-bet related transcription factor involved in IFN-γ production in cytotoxic cells 28 (Fig. 3c) . Analyses of Runx protein expression showed up-regulation of Runx3 in Thpok pd effector cells, which predominated over Runx1 (Fig. 3h) , demonstrating that ThPOK is important to restrain Runx3 expression during T cell activation. Impaired production of IL-4 was not restored by co-culture with wild-type CD4 + T cells or by neutralizing IFN-γ activity during activation, indicating that it was intrinsic to ThPOK-deficient CD4 + T cells (Fig. 3i,j) . A 10-fold excess of wild-type CD4 + T cells in the culture only modestly improved IL-4 expression by ThPOK-deficient CD4 + T cells activated under T H N conditions (Fig. 3i ). These experiments demonstrate a cell-intrinsic role for ThPOK in IL-4 production and T H 2 differentiation. Disruption of Runx activity (by inactivating Cbfβ) restored IL-4 production in effector cells generated from naïve Thpok pd Cbfb pd CD4 + T cells activated under T H N conditions ( Supplementary Fig. 4a ). Thus, Eomes mediates IFN-γ production but not IL-4 repression caused by unrestrained Runx activity in ThPOK-deficient effectors. This agrees with our finding that the impaired T H 2 differentiation of ThPOKdeficient cells was not the consequence of excessive IFN-γ production (Fig. 3j) . We conclude from these experiments that ThPOK repression of Runx3 in CD4 + T cells is essential for T h 2 responses, as it prevents Runx3-mediated activation of a cytotoxic gene expression program and, independently, the repression of IL-4.
ThPOK protects T H 1 differentiation by constraining Runx functions
Because wild-type T H 1 effector cells normally express Runx3 18, 19 , we investigated if ThPOK also affected T H 1 differentiation. In T cells polarized in T H 1 conditions, ThPOK disruption had little effect on Runx3 or IFN-γ expression (Fig. 5a,b) . However, compared to their Thpok +/+ counterparts, Thpok pd effector cells generated in T H 1 conditions had greater expression of CD8 and granzyme B and they externalized CD107a, a marker of cytotoxic cell degranulation 31 (Fig. 5b) . Of note, they retained CD4 expression ( Supplementary Fig.  5a ).
These observations suggested that a comparison of the transcriptomes of wild-type and ThPOK-deficient T H 1 effector cells would reveal how ThPOK affects gene expression independently of its effect on Runx3 expression. Thus, we used gene expression arrays to compare the transcriptional profiles of the following effector T cells, all generated in the same T H 1 polarizing conditions:(i) wild-type T H 1 CD4 + T cells, generated from naïve CD4 + T cells, (ii) Thpok pd CD4 + CD8 − and CD4 + CD8 + cells, the two populations generated by activation of naive Thpok pd CD4 + CD8 − cells ( Supplementary Fig. 5a ), and (iii) wild-type cytotoxic CD8 + T cells, generated from naïve CD8 + T cells. Except for Cd8 genes, side by side comparisons showed no divergence between CD4 + CD8 − and CD4 + CD8 + Thpok pd T effector cells generated in these conditions (Fig. 5c , top left, and Supplementary Fig. 5b ). When we compared Thpok pd CD4 + CD8 + to wild-type CD4 + and CD8 + T effector cells, Thpok pd CD4 + CD8 + had a transcriptional profile that was very similar to that of wild-type CD8 + cytotoxic cells (Fig. 5c , bottom left), whereas they diverged from the wild-type CD4 + T H 1 cells almost to the same extent as wild-type cytotoxic T cells did (Fig. 5c , right two plots). Thus, ThPOK is responsible for the bulk of differential gene expression between T H 1 CD4 + and cytotoxic CD8 + T cells.
Hierarchical clustering distinguished two groups of genes differentially expressed between
Thpok pd CD4 + CD8 + (or CD4 + CD8 − ) and wild-type CD4 + T effector cells ( Fig. 5d and Supplementary Fig. 5b ). The largest group represented genes up-regulated in each ThPOKdeficient subset in comparison to wild-type CD4 + T cells. In addition to prototypical cytotoxic genes such as perforin or Granzymes A and B, this group included most of the genes preferentially expressed in CD8 + T effector cells but which are not part of the conventional cytotoxic program, such as IL-10, Zbtb32 (encoding the transcription factor Rog) as well as cell cycle-related genes. The second group contained a smaller gene set that was down-regulated in each ThPOK-deficient subset compared to wild-type CD4 + T cells and comprised genes involved in effector T cell differentiation, such as Cd40lg or Vipr1 (encoding a receptor for the VIP peptide) and molecules involved in cell adhesion (Amigo2) or trafficking (Ccr7, S1pr1). Indeed, Thpok pd T effector cells (CD4 + CD8 + and CD4 + CD8 − ) had impaired induction of CD40L (Fig. 5e, bottom) ; of note, this contrasted with the conserved CD40L expression in naïve Thpok pd CD4 + T cells (Fig. 5e, top) , which express little Runx3.
The repression of the cytotoxic program by ThPOK in T H 1 effector cells supported the conclusion that this factor, in addition to repressing Runx3, restrained Runx-mediated activation of cytotoxic genes. Indeed, the cytotoxic gene up-regulation characteristic of ThPOK-deficient effector cells was reverted in Thpok pd Cbfb pd effector cells derived in T H 1 cultures from naïve CD4 + CD8 − T cells (Fig. 5f ).
In addition to activating effects, Runx proteins have repressive functions, notably on Cd4 and Thpok during T cell differentiation 24 . While ThPOK can antagonize Runx-mediated repression 11, 32 , the physiological relevance of such antagonism has not been established, and was questioned by the continued expression of CD4 in Runx3-expressing ThPOKdeficient T effector cells (Supplementary Fig. 5a ). Thus, we next examined if the ThPOKdependence of helper effector gene expression, such as Cd40lg, was explained by ThPOK antagonism of Runx-mediated repression. Indeed, Cbfβ disruption enhanced CD40L expression in Thpok pd Cbfb pd T H 1 effector cells (Fig. 5g ). These observations demonstrate that ThPOK promotes effector gene expression at least in part by antagonizing Runxmediated repression. We conclude from these experiments that ThPOK is essential to protect helper and restrain cytotoxic gene expression by antagonizing Runx3 functions.
Thpok is important for antigen-induced T cell responses in vivo
We took two approaches to examine how ThPOK expression affects CD4 + T cell responses in vivo. First, we evaluated responses to Toxoplasma gondii, an intra-cellular parasite generating a massive IFN-γ-mediated CD4 + T H 1 response, during which we tracked T cells reacting against a specific MHC II-presented parasite epitope (AS-15) 33 . At the peak of the acute response, similar frequencies of IFN-γ-producing CD4 + T effector cells were found in both Thpok pd and wild-type controls ( Supplementary Fig. 6a ). ThPOK disruption did not affect the number of AS-15-reacting T cells (Fig. 6a,b) and did not increase parasite load ( Supplementary Fig. 6b ). However, consistent with the notion that ThPOK prevents cytotoxic gene expression in T H 1 cells, Thpok pd effector cells were CD4 + CD8 + and expressed granzyme B and Eomes (Fig. 6a,c and Supplementary Fig. 6c ).
We considered the possibility that signals from other cells involved in T. gondii responses, including innate immune cells and CD8 + T cells, could help CD4 + T cells overcome ThPOK deficiency. Thus, in a second approach, we examined the cell intrinsic role of ThPOK in a defined, clonotypic CD4 + T cell response. We compared the antigen-driven expansion of ThPOK-deficient and -sufficient cells carrying the ovalbumin-specific OT-II TCR. We purified wild-type or Thpok pd CD4 + CD8 − OT-II T cells, and assessed their response after adoptive transfer into ovalbumin-immunized wild-type lympho-replete hosts. We found that the amplification of Thpok pd CD4 + CD8 − OT-II T cells was blunted compared to their wildtype counterparts, and that these Thpok pd cells re-expressed CD8, while maintaining CD4 (Fig. 6d,e) . Thus, even if ThPOK is not required for the generation of antigen-responsive effector T cells, it is important for their proper expansion and differentiation.
Thpok and LRF redundantly maintain CD4 + -lineage integrity
The puzzling persistence of CD4 expression in Thpok pd effector T cells, despite their high Runx3 expression, contrasted with their Runx-dependent repression of CD40L, or the Runxdependent repression of CD4 in naïve CD4 lo Thpok pd cells (Fig. 1h, i) . This raised the possibility that the Cd4 locus was no longer sensitive to Runx-mediated repression in antigen-stimulated T cells. Consistent with this possibility, naïve CD4 lo Thpok pd cells, in which CD4 repression is Runx-dependent (Fig. 1i) up-regulated CD4 upon activation ( Supplementary Fig. 7a ). An alternative possibility was that Cd4 expression in T H 1 effector cells remained responsive to Runx-mediated repression, but was sustained by a redundant factor in the absence of ThPOK. The transcription factor LRF, which has a ThPOK-redundant role in promoting CD4 + T cell programming in the thymus 16 represented an obvious candidate.
To distinguish between these possibilities, we generated Thpok fl/fl Zbtb7a fl/fl mice carrying the CD2-Cre transgene (hereafter Thpok pd Zbtb7a pd mice), in which both Thpok and Zbtb7a, which encodes LRF, are deleted in naïve peripheral T cells. The isolated disruption of LRF did not affect CD4 + T cell expression of CD4 or CD8, or functional differentiation (data not shown and Ref. 16 ). Compared to Thpok pd mice, Thpok pd Zbtb7a pd mice showed little effect of Zbtb7a disruption on thymic development, but they had reduced peripheral CD4 + CD8 − and CD4 lo T cell subsets ( Supplementary Fig. 7b,c,d Fig. 7e ). Rather, LRF antagonized Runxmediated Cd4 repression. In transient transfection experiments that evaluate the activity of a GFP-based reporter construct including Cd4 cis-regulatory elements (promoter, proximal enhancer and silencer) 24 , Runx3 repressed Cd4 reporter activity, whereas ThPOK, while having no effect per se, prevented Runx-mediated repression 32 (Fig. 7b) . LRF was as efficient as ThPOK at antagonizing Runx-mediated repression of the Cd4 reporter (Fig. 7b) . Of note, ThPOK and LRF disruption did not prevent T H 17 differentiation in vitro (Fig. 7c) , indicating that ThPOK and LRF were not required for T H 17 differentiation in post-thymic cells, unlike their function in the thymus 16 . These results suggest that a transcriptional node defined by the overlapping activities of ThPOK and LRF supports CD4 expression in mature T cells.
Thpok expression is sustained independently of Thpok and LRF
Because ThPOK was proposed to protect expression of both Cd4 and Thpok genes 11 , the previous findings suggested that ThPOK and LRF would also contribute to sustain Thpok expression; that is, that the Thpok promoter would be inactive in Thpok pd Zbtb7a pd transdifferentiated CD4 − CD8 + cells. Cre-mediated inactivation of the Thpok fl allele excises most of its transcribed sequences, therefore preventing direct gene expression analyses. Thus, we used a Thpok GFP BAC reporter 22 , genetically independent from the Thpok locus, to test this possibility. Inactivation of ThPOK, or both ThPOK and LRF, had little or no effect on reporter expression in naïve CD4 + cells (Fig. 7d) . In addition, the reporter was also expressed in Thpok pd Zbtb7a pd T H 1 effector cells, including those trans-differentiating into CD4 − CD8 + cells (Fig. 7e) . Thus, while ThPOK and LRF control lineage integrity and effector differentiation of CD4 + T cells, they are dispensable for Thpok gene expression.
Discussion
The present study demonstrates that the transcription factor ThPOK, redundantly with its homolog LRF, sustains the phenotypic and functional integrity of the CD4 + lineage.
ThPOK's impact in mature T cells is mediated both by its repression of Runx3 expression and its antagonism of Runx protein function. Thus, not only do ThPOK and LRF establish functional helper pre-programming in thymocyte 16 , they are continuously needed to maintain the integrity of helper T cell responses.
Using a novel mouse strain which targets Cre expression to naïve T cells with greater selectivity than existing lines 34 , we demonstrate that the ThPOK-LRF transcriptional 'node' is required to maintain CD4 + lineage integrity beyond the thymic checkpoint that defines CD4 + -lineage commitment. The contribution of ThPOK and LRF to CD4 expression is important because CD4 is needed for the survival and fitness of mature CD4 + T cells 35 . Conversely, repression by ThPOK of genes encoding CD8α and CD8β fits with previous reports that ThPOK functionally and physically targets Cd8 enhancers [36] [37] [38] . However, our findings underscore a fundamental difference between CD4 + and CD8 + T cells for coreceptor gene repression. Once established in CD8SP thymocytes by recruitment of the Cd4 repressor Runx3 to the Cd4 silencer, Cd4 silencing is epigenetically maintained independently of Runx3 or the silencer 24, 39 . This contrasts with the active repression of Cd8 in CD4 + T cells.
Our study demonstrates that ThPOK broadly represses cytotoxic gene expression and thereby avoids the 'cytotoxic diversion' of T H 2 effectors. The balance between Runx3 and GATA3 controls T H 1-T H 2 differentiation in CD4 + T cells 18, 19, 30 . Runx molecules inhibit IL-4 and promote IFN-γ expression presumably both directly and indirectly, by binding to Il4 and Ifng genes and controlling expression of GATA3 and T-bet. GATA3 antagonizes both direct and indirect effects, at least in part through direct binding to Runx3 molecules 30 . By limiting the amount of Runx3 produced during CD4 + T cell activation, ThPOK is critical for T H 2 differentiation. ThPOK disruption results in Runx-dependent Eomes expression, which is needed for IFN-γ production but not to prevent IL-4 expression. This finding supports the conclusions that Il4 repression and Ifng activation are mechanistically independent: the former being principally mediated by Runx3 whereas Ifng activation by Runx3 requires Eomes or T-bet, even though Runx3 binds the Ifng gene 18, 30 In addition to repressing Runx3, ThPOK antagonizes Runx protein activity, the latter function underpinning ThPOK's support for Cd40lg expression and its impact on T H 1 differentiation. While such antagonism of Runx function had been identified in cell lines and thymocytes 11, 32 , our study establishes its physiological relevance by comparing the transcriptome of ThPOK-deficient and -sufficient cells with equivalent expression of Runx proteins. Future experiments will explore whether such mechanisms are important for long term control of intra-cellular pathogens which relies on T H 1 responses, including of T. gondii. The central role of CD4 + effector cells for long term T. gondii control 41 , including providing help to CD8 + T, B, and myeloid cells, notably through CD40L 40 , suggests that the function of ThPOK in maintaining the T H 1 circuitry may be essential to coordinate such responses.
ThPOK was reported to 'protect' the colitogenic potential of CD4 + T cells in adoptive cell transfer colitis in alymphoid mice 17 , a function assigned to ThPOK promoting the differentiation of colitogenic T H 17 cells. However, both that report 17 and our study found that ThPOK is not needed for in vivo T H 17 responses. Furthermore, ThPOK inhibits, rather than protects, T H 17 differentiation in invariant natural killer (iNK T) cells 42 . We note that ThPOK's control of CD40L in T H 1 effectors provides an alternative rationale for its impact on adoptive transfer colitis. Indeed, T H 1 cells are instrumental in this disease, in which CD40L is critical to induce gut inflammation 43, 44 .
It was recently proposed that the expression of Thpok in CD4 + T cells is subject to regulation, namely that Runx3 up-regulation by environmental signals represses Thpok in CD4 + effector cells by activating a Thpok silencer 17, 38 . However, even though the Thpok silencer includes binding sites for Runx molecules 13 , such repression did not in fact require Runx3 17 . Nonetheless, given that ThPOK has been reported to protect the Thpok gene from repression by Runx molecules 11 , we expected that inactivation of ThPOK, or ThPOK and LRF, would facilitate Thpok repression by Runx3. Contrary to this prediction, the Thpok locus remained transcriptionally active in Runx3-expressing ThPOK-LRF double-deficient cells, challenging the idea that Runx3 expression initiates Thpok silencing in effector T cells. Rather, such silencing, if physiologically relevant, could be caused by signals targeting other repressors of Thpok expression 45, 46 .
In primate T cells, CD4 serves as receptor for the human immunodeficiency virus (HIV) and its simian homologs (SIV) 47 . Notably, it was found that antigen-experienced MHC IIrestricted cells convert from a CD4 + CD8 − to a CD4 − CD8α lo β − phenotype in African green and Patas monkeys 48, 49 . Although such conversion is associated with reduced expression of helper genes, it is believed to be beneficial by protecting the helper T cell population from SIV infection and the ensuing immunodeficiency. The present study provides a conceptual framework to investigate the mechanisms of this conversion, in which the association of functional changes with a concerted switch of CD4 and CD8 expression suggests the possible involvement of Runx molecules and their control by ThPOK or related factors.
In summary, our findings emphasize the inherent instability of the CD4 + lineage, that ThPOK, together with LRF, continuously protects from CD8 + trans-differentiation. They indicate that changes in expression or activity of these factors have broad consequences on T helper functions, making them potential targets for physiological control and therapeutic intervention.
analyzed between 6 and 16 weeks of age. Animal procedures were approved by the NCI Animal Care and Use Committee.
Antibodies
Antibodies for the following specificities were purchased either from Affymetrix eBiosciences or BD Pharmingen: CD4 (RM4.4 or GK1.5), CD8α (53-6-7), CD8β (53-5.8), CD24 (M1/89), TCRβ (H57-597), CD40L (MR1), CD107a (1D4B), GATA3 (TWAJ), Tbet (4B10), eomes (Dan11mag), IL4 (11B11), CD45.2 (104), Va2 (B20.1), IFN-g (XMG1. 2), IL17a,(eBio17B7) CD44 (IM7). Antibodies specific for Granzyme B (GB12) were purchased from Invitrogen. TGME49 Class II I-A b tetramers loaded with the AS-15 peptide, and control Clip peptide-loaded I-A b tetramers were obtained from the NIH tetramer facility.
Cell preparation and staining
Lymph node, spleen, thymus and intestinal lymphocytes were prepared and stained as previously described 10, 22, 54 . Flow cytometry data were acquired on LSR II or LSR Fortessa cytometers (BD Biosciences) and analyzed with FlowJo (TreeStar) software. Dead cells and doublets were excluded by DAPI and forward scatter height by width gating. Purification of lymphocytes by cell sorting was performed on a FACSAria (BD Biosciences). Analyses of intracellular cytokines and transcription factors was performed as previously described 10, 16 .
In vitro analysis of gene and protein expression
Analysis of CD40L expression was performed as previously described 16 . Effector T cells were generated from sorted CD44 lo (naïve) T cells from spleen or LN as previously described 10 , except that activating and blocking antibodies were purchased from BioXCell. Transfection of RLM-11 cells was performed as previously described 32 . Analysis of ThPOK and Runx protein expression was performed by Western blot as previously described using an antiserum against ThPOK 22 and anti-Runx antibody (EPR3099, Epitomics). Membranes were subsequently stripped and blotted with anti β-actin (AC-15, Sigma) to control for lane loading. Quantification of cytokine production by ELISA was performed on culture supernatants 5 days after activation without additional restimulation, using mouse DuoSet ELISA kits (R&D Systems) and following the manufacturer's instruction.
Adoptive transfer and immunization
For analyses of coreceptor expression in naïve cells, sorted CD45.2 + CD44 lo CD4 + CD8 − T cells (2×10 6 ) from spleen and or lymph nodes of Thpok +/+ or Thpok pd mice were injected intravenously into CD45.1 recipients, which were analyzed 14 days later. For OVA-specific responses, 30,000 sorted CD45.2 + CD44 lo CD4 + CD8 − T cells from spleen and or lymph nodes of OT-II TCR transgenic Thpok +/+ or Thpok pd mice were injected into CD45.1 recipients, followed by immunization with 100ug OVA emulsified in complete Freund's adjuvant administered by intraperitoneal (i.p.) injection 18 hours after adoptive transfer. Mice were analyzed 4-6 days post-immunization.
Schistosoma mansoni infections were performed essentially as previously described 26 . Briefly, mice were injected i.p. with 2500 inactivated (freeze-thaw) eggs, then boosted 8 days later with a second dose of 2500 inactivated egg dose. Eggs were stored at −70°C before use. Mice were analyzed 12-14 days after the initial injection.
Granule exocytosis assay
In vitro activated T cells from 5 day cultures were re-stimulated on anti-CD3 coated plates, for 4 hours at 37°C, 5% CO 2 in the presence of PE-labeled anti-CD107a. Cells were harvested, washed and surface stained before flow cytometric analysis.
Infections
Infection of mice with C. rodentium was performed as previously described. 55 Mice were analyzed between 8 to 12 days post-infection. ME-49 clone C1 of T. gondii (kindly provided by Dr M.E. Grigg, NIAID) was obtained by electroporation of the parental ME-49 type II strain (ATCC 50840) with the red fluorescent protein (RFP) and was used for production of tissue cysts in C57BL/6 mice. Mice were infected with 10 cysts by oral gavage. Tissues were harvested between 9 and 14 days post-infection and analyzed as described 56 . Parasite load was evaluated by the frequency of RFP-expressing cells in the spleen of infected animals.
Microarray analyses
Sorted naïve (CD44 lo ) CD4 + CD8 − and CD4 − CD8 + T cells, from wild-type mice, and CD4 + CD8 − cells, from Thpok pd mice were activated in vitro in T H 1 conditions and sorted again 4 days later into purified CD4 + CD8 − and CD4 − CD8 + (wild-type) and CD4 + CD8 − and CD4 + CD8 + (Thpok pd ) subsets. Total RNA was extracted from sorted subsets and processed for microarray analyses (Affymetrix Mouse Exon 1.0 ST array) at the NCI microarray facility, following the manufacturer's recommendation. Data is from 3 replicates (except wild-type CD4 − CD8 + cells, for which two samples only were processed) generated from two distinct cell preparations. Data was analyzed with Partek Genomic Suite and deposited in the GEO database under accession number GSE57846.
Statistical analyses
All statistical analyses were performed using Prism software. Bars in graphs indicate average ± SEM. Except where otherwise indicated, comparisons were performed by twotailed unpaired t-test; F-test was performed to check the assumption of equal variance. Twotailed paired t-test was used where biologically appropriate (e.g. cytokine assays processed in parallel). Significance levels (P-values) are indicated on figures. For statistical comparisons, sample size was always greater than 3 and determined empirically based on pilot analyses. We used neither randomization nor blinding since comparisons involve mice of distinct genotypes; animals were excluded from analyses only on the basis of age or poor health status unrelated to the experiment.
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